The opioid use disorder treatment market consists of medication-assisted treatment (MAT) such as buprenorphine and methadone and extended-release injection treatment. These treatments are aimed at managing withdrawal symptoms, reducing opioid abuse related harms and decreasing the desire to use opioids. MAT has shown to improve treatment retention and reduce the use of illicit opioids.

The global opioid use disorder treatment market is estimated to be valued at US$ 3728.51 Bn ... Read more

Opioid use disorder, previously known as opioid addiction or opioid dependency, is a serious medical illness caused by regular use of prescription opioids, heroin, or other opiates. Opiates are found naturally in opium derived from the poppy plant and synthetic opioids created in labs. Commonly misused prescription opioids include oxycodone, hydrocodone, codeine, morphine, and fentanyl. Opioid use disorder develops when a person's brain and behavior become adapted to the presence of opioids ... Read more